APMC AmperCap Acquisition Co

Executive Summary

AmperCap Acquisition Co. completed its $125 million SPAC IPO (12,500,000 units at $10.00/unit) on June 2, 2026. The units consist of one ordinary share and one right to receive 1/10 of an ordinary share upon a future business combination. Concurrently, the sponsor, underwriter, and third-party investors purchased 512,500 private placement units for $5.125 million. Proceeds of $126.25 million are deposited in a trust account, with $800,000 for working capital. The company has 21 months to find an acquisition target, with a stated focus on US-Mexico cross-border middle-market companies. The IPO represents a routine capital formation event for a blank-check company; no operating business or target has been identified.

Key Financial Metrics

Actionable Insight

Key Facts

• Priced IPO of 12,500,000 units at $10.00/unit for gross proceeds of $125,000,000.
• Each unit consists of one ordinary share and one right to receive 1/10 of an ordinary share upon a future business combination.
• Underwriters have a 45-day option to purchase up to an additional 1,875,000 units for over-allotments.
• Concurrent private placement of 512,500 units at $10.00/unit to sponsor, EBC, and third-party investors for total proceeds of $5,125,000.
• Of the combined proceeds, $126,250,000 will be deposited into a trust account ($10.10 per public share), with approximately $800,000 for working capital and offering expenses.
• Company has 21 months from closing to complete a business combination, or it must liquidate and return trust proceeds to public shareholders.
• Sponsor and initial shareholders hold founder shares purchased at ~$0.005/share, creating a significant dilution incentive for public shareholders.
• Units (APMCU), ordinary shares (APMC), and rights (APMCR) to list on Nasdaq.
• Underwriters: EarlyBirdCapital (book-runner) and Clear Street (co-manager). Underwriting commission is $0.20 per unit ($2,500,000 total).

Financial Impact

Gross IPO proceeds of $125,000,000; concurrent private placement yields $5,125,000; $126,250,000 deposited into trust account at $10.10 per public share.

Risk Factors

• Failure to complete a business combination within 21 months would result in liquidation, returning ~$10.10 per share to public holders, making rights worthless.
• Substantial dilution from founder shares purchased at $0.005/share vs. public offering price of $10.00/share.
• No identified target business; management may pursue a lower-quality deal to meet the deadline, incentivized by their nominal cost basis.
• CFIUS or other regulatory risks given the stated cross-border US-Mexico focus and Mexican citizenship of co-CEOs.
• Potential for significant shareholder redemptions at the time of a business combination, limiting cash available for the deal.

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status

Related Tickers